Type: device
Status: Approved and commercially available
Developer: Senseonics / Sequel Med Tech
First interoperable implanted CGM paired with an insulin pump. The Eversense 365 sensor lasts a full year under the skin, while Twiist provides automated insulin delivery. Eliminates weekly sensor changes.
365-day implanted CGM sensor paired with automated insulin delivery pump
Year: 2026